TANG CAPITAL MANAGEMENT LLC 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-04 6:57 pm Purchase |
2025-03-28 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
TANG CAPITAL MANAGEMENT LLC | 2,178,609 5.200% |
2,178,609 (New Position) |
Filing |